Creative Medical Technolo... (CELZ)
NASDAQ: CELZ
· Real-Time Price · USD
3.05
-0.02 (-0.65%)
At close: Aug 15, 2025, 3:59 PM
3.12
2.30%
After-hours: Aug 15, 2025, 06:53 PM EDT
Creative Medical Technology Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 6.54M | 7.7M | 5.94M | 6.26M | 7.47M | 9.01M | 3.47M | 4.51M | 3.99M | 9.52M | 18.4M | 21.99M | 22.86M | 9.15M | 10.72M | 2.38M | 158.59K | 275.13K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | 6.52M | 7.47M | 9.58M | 5.04M | 10.08M | 5.02M | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 3.28K | 3.28K | 3.28K | 3.28K | 3.28K | 3.28K | 3.28K | 3.28K | 3.28K | 3.28K | 3.28K | 3.28K | 3.28K | 3.28K | 3.28K | 3.28K | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -64.96K | -64.96K | 2.48K | n/a | n/a | n/a |
Inventory | 994.00 | 994.00 | 2.19K | 3.39K | 3.39K | 6.59K | 6.59K | 7.79K | 10.19K | 10.19K | 10.19K | 15.89K | 20.63K | 14.15K | 10.87K | n/a | n/a | n/a |
Other Current Assets | 87.59K | 140.15K | 192.71K | 67.61K | 129.09K | 190.56K | 277.25K | 61.48K | 153.69K | 245.91K | n/a | n/a | 64.96K | 64.96K | n/a | 200K | n/a | n/a |
Total Current Assets | 6.63M | 7.84M | 6.14M | 6.33M | 7.6M | 9.2M | 10.27M | 12.04M | 13.73M | 14.81M | 18.75M | 22.01M | 22.95M | 9.23M | 10.74M | 2.58M | 158.59K | 275.13K |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | 469.24K | 499.98K | 530.56K | 553.2K | 382.47K | 411.74K | 441.01K | 466.53K | 389.55K | 412.57K | 435.6K | 458.62K | 481.64K | 504.66K | 527.68K | 550.7K | 573.72K | 596.74K |
Total Long-Term Assets | 472.52K | 503.26K | 533.84K | 556.48K | 385.75K | 415.02K | 444.29K | 469.81K | 392.83K | 415.86K | 438.88K | 461.9K | 484.92K | 507.94K | 530.96K | 553.98K | 573.72K | 596.74K |
Total Assets | 7.11M | 8.35M | 6.67M | 6.89M | 7.99M | 9.62M | 10.72M | 12.51M | 14.13M | 15.23M | 19.19M | 22.47M | 23.43M | 9.73M | 11.27M | 3.13M | 732.31K | 871.88K |
Account Payables | 263.45K | 272.19K | 273.53K | 273.79K | 322.16K | 336.85K | 317.28K | 367.05K | 344.41K | 353.42K | 3.27M | 327.84K | 310.68K | 335.68K | 761.86K | 454.52K | 365.04K | 356K |
Deferred Revenue | n/a | n/a | n/a | n/a | -14.19K | -14.19K | n/a | n/a | -14.19K | -14.19K | -14.19K | n/a | -14.19K | -14.19K | -14.19K | 17.3K | 611.36K | 355.64K |
Short-Term Debt | n/a | 14.19K | 14.19K | 14.19K | 14.19K | 14.19K | 14.19K | 14.19K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.74M | 222.27K | 327.23K |
Other Current Liabilities | 14.19K | -14.19K | 39.92K | n/a | 14.19K | 14.19K | n/a | n/a | 14.19K | 14.19K | 14.19K | 14.19K | 14.19K | 14.19K | 264.19K | 267.38K | 248.1K | 2.28M |
Total Current Liabilities | 277.64K | 286.39K | 327.64K | 330.91K | 376.27K | 390.96K | 371.39K | 421.16K | 398.53K | 407.54K | 3.32M | 396.96K | 389.8K | 379.8K | 1.05M | 3.5M | 1.45M | 3.31M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 353.42K | 3.27M | n/a | 310.68K | 335.68K | 761.86K | n/a | n/a | n/a |
Total Liabilities | 277.64K | 286.39K | 327.64K | 330.91K | 376.27K | 390.96K | 371.39K | 421.16K | 398.53K | 407.54K | 3.32M | 396.96K | 389.8K | 379.8K | 1.05M | 3.5M | 1.45M | 3.31M |
Total Debt | n/a | 14.19K | 14.19K | 14.19K | 14.19K | 14.19K | 14.19K | 14.19K | 14.19K | 14.19K | 14.19K | 14.19K | 14.19K | 14.19K | 14.19K | 2.74M | 222.27K | 327.23K |
Common Stock | 2.59K | 2.59K | 1.75K | 1.43K | 1.43K | 1.43K | 1.43K | 1.43K | 1.43K | 14.08K | 14.08K | 14.08K | 13.96K | 6.52K | 6.34K | 2.46K | 1.22M | 1.14M |
Retained Earnings | -67.46M | -66.23M | -64.59M | -62.74M | -61.7M | -60.14M | -59.1M | -57.42M | -55.97M | -54.86M | -53.81M | -47.6M | -46.61M | -44.82M | -43.67M | -38.8M | -36.96M | -34.05M |
Comprehensive Income | n/a | n/a | n/a | n/a | -1.43K | n/a | n/a | n/a | -0.00 | 0.00 | 0.00 | -0.00 | n/a | n/a | -0.00 | n/a | n/a | n/a |
Shareholders Equity | 6.83M | 8.06M | 6.34M | 6.56M | 7.61M | 9.23M | 10.34M | 12.09M | 13.73M | 14.82M | 15.86M | 22.07M | 23.04M | 9.35M | 10.22M | -363.35K | -714.45K | -2.44M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | 6.52M | 7.47M | 9.58M | 5.04M | 10.08M | 5.02M | n/a | n/a | n/a | n/a | n/a | n/a |